Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Abstract 4613: Differential TROP2 immunohistochemical expression between pleomorphic and classic invasive lobular carcinoma of the breast

Elizve Barrientos-Toro, Harsh Batra, Pandurengan Renganayaki, Yasmeen Qamar Rizvi, Jason Aboudi Mouabbi, Funda Funda Meric-Bersntam, Qingqing Ding, Aysegul Sahin, Maria Gabriela Raso

Cancer Res (2025) 85 (8_Supplement_1): 4613.

https://doi.org/10.1158/1538-7445.AM2025-4613

Published: 21 April 2025

View articletitled, Abstract 4613: Differential TROP2 immunohistochemical expression between pleomorphic and classic invasive lobular carcinoma of the breast

Journal Articles

Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Mi Li, Amriti R. Lulla, Yan Wang, Spyros Tsavaschidis, Fuchenchu Wang, Cansu Karakas, Tuyen D.T. Nguyen, Tuyen N. Bui, Marc A. Pina, Mei-Kuang Chen, Sofia Mastoraki, Asha S. Multani, Natalie W. Fowlkes, Aysegul Sahin, C. Gary Marshall, Kelly K. Hunt, Khandan Keyomarsi

Cancer Res (2024) 84 (22): 3864–3880.

https://doi.org/10.1158/0008-5472.CAN-23-4130

Published: 15 November 2024

View articletitled, Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract PO3-15-03: Abemaciclib is effective in palbociclib resistant estrogen receptor positive breast cancers

Juliana Navarro-Yepes, Nicole Kettner, Xiayu Rao, Tuyen Bui, Cassandra Bishop, Hannah Wingate, Akshara Singareeka Raghavendra, Yan Wang, Jing Wang, Aysegul Sahin, Funda Meric-Bernstam, Kelly Hunt, Senthil Damodaran, Debu Tripathy, Khandan Keyomarsi

Cancer Res (2024) 84 (9_Supplement): PO3-15-03.

https://doi.org/10.1158/1538-7445.SABCS23-PO3-15-03

Published: 02 May 2024

View articletitled, Abstract PO3-15-03: Abemaciclib is effective in palbociclib resistant estrogen receptor positive breast cancers

Journal Articles

Abstract P2-21-07: Exploring spatial correlations in Breast invasive Lobular Carcinoma subtypes using a novel CAF multiplex immunofluorescence panel

Harsh Batra, Renganayaki K. Pandurengan, Heladio P. Ibarguen, Salome A McAllen, Qingqing Ding, Aysegul Sahin, Ignacio Wistuba, Edwin Roger Parra, Maria Gabriela Raso

Cancer Res (2023) 83 (5_Supplement): P2-21-07.

https://doi.org/10.1158/1538-7445.SABCS22-P2-21-07

Published: 01 March 2023

View articletitled, Abstract P2-21-07: Exploring spatial correlations in Breast invasive Lobular Carcinoma subtypes using a novel CAF multiplex immunofluorescence panel

Journal Articles

Abstract 1798: Mechanisms of acquired resistance to palbociclib reveals pathways of response to abemaciclib

Juliana Navarro-Yepes, Nicole M. Kettner, Tuyen Bui, Akshara S. Raghavendra, Xiayu Rao, Jing Wang, Aysegul Sahin, Senthil Damodaran, Debasish Tripathy, Kelly K. Hunt, Khandan Keyomarsi

Cancer Res (2022) 82 (12_Supplement): 1798.

https://doi.org/10.1158/1538-7445.AM2022-1798

Published: 15 June 2022

View articletitled, Abstract 1798: Mechanisms of acquired resistance to palbociclib reveals pathways of response to abemaciclib

Journal Articles

Abstract 515: Single-cell transcriptomic analysis of HR+/HER2- breast cancer identifies gene signatures that predict outcomes of luminal A and B subtypes

Sofia Mastoraki, Jerome Lin, Xiayu Rao, Sophie R. Liu, Harsh Batra, Maria G. Raso, Edwin R. Parra Cuentas, Akshara S. Raghavendra, Komal S. Rasaputra, Min Yi, Jing Wang, Aysegul Sahin, Debasish Tripathy, Kelly K. Hunt, Nicholas E. Navin, Khandan Keyomarsi

Cancer Res (2022) 82 (12_Supplement): 515.

https://doi.org/10.1158/1538-7445.AM2022-515

Published: 15 June 2022

View articletitled, Abstract 515: Single-cell transcriptomic analysis of HR+/HER2- breast cancer identifies gene signatures that predict outcomes of luminal A and B subtypes

Journal Articles

Abstract P4-07-13: An exploratory case-control study of perineural invasion in breast cancer

Solange Erlyn Cox, Roland Bassett, Min Yi, Aysegul Sahin, Mediget Teshome, Kelly Hunt, Catherine Akay

Cancer Res (2022) 82 (4_Supplement): P4-07-13.

https://doi.org/10.1158/1538-7445.SABCS21-P4-07-13

Published: 15 February 2022

View articletitled, Abstract P4-07-13: An exploratory case-control study of perineural invasion in breast cancer

Journal Articles

Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)

Cancer Res (2021) 81 (4_Supplement): PS18-04.

https://doi.org/10.1158/1538-7445.SABCS20-PS18-04

Published: 15 February 2021

View articletitled, Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)

Journal Articles

Abstract PS18-37: Loss of Trop2 protein in metaplastic carcinoma of breast by IHC

Fei Yang, Yasmeen Rizvi, Erkan Yuca, Ming Zhao, Kurt Evans, Xiaofeng Zheng, Aysegul Sahin, Funda Meric-Bernstam

Cancer Res (2021) 81 (4_Supplement): PS18-37.

https://doi.org/10.1158/1538-7445.SABCS20-PS18-37

Published: 15 February 2021

View articletitled, Abstract PS18-37: Loss of Trop2 protein in metaplastic carcinoma of breast by IHC

Journal Articles

Abstract P4-06-03: Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

Sofia Mastoraki, Juliana Navarro-Yepes, Tuan Tran, Aysegul Sahin, Kelly Hunt, Nicholas Navin, Khandan Keyomarsi

Cancer Res (2020) 80 (4_Supplement): P4-06-03.

https://doi.org/10.1158/1538-7445.SABCS19-P4-06-03

Published: 15 February 2020

View articletitled, Abstract P4-06-03: Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

Journal Articles

Abstract P1-18-20: Breast cancer with HER2 FISH test result in group 2: Should HER2 test be repeated?

Hui Chen, Minhua Wang, Hongxia Sun, Jun Gu, Zhenya Tang, Guilin Tang, Steven Sfamenos, Melissa Robinson, Aysegul Sahin

Cancer Res (2020) 80 (4_Supplement): P1-18-20.

https://doi.org/10.1158/1538-7445.SABCS19-P1-18-20

Published: 15 February 2020

View articletitled, Abstract P1-18-20: Breast cancer with HER2 FISH test result in group 2: Should HER2 test be repeated?

Journal Articles

Abstract 1105: Tumor cells of the early metastatic process show up regulation of cytokine genes involved in migration of inflammatory cells

Coya Tapia, Xiaoping Su, Ximing Tang, Lakshmi Kakaral, Aysegul Sahin, Wei Lu, Ignacio I. Wistuba

Cancer Res (2018) 78 (13_Supplement): 1105.

https://doi.org/10.1158/1538-7445.AM2018-1105

Published: 01 July 2018

View articletitled, Abstract 1105: Tumor cells of the early metastatic process show up regulation of cytokine genes involved in migration of inflammatory cells

Journal Articles

Abstract 907: Brain microenvironment induced PTEN loss by microRNAs promotes brain metastasis

Cancer Res (2016) 76 (14_Supplement): 907.

https://doi.org/10.1158/1538-7445.AM2016-907

Published: 15 July 2016

View articletitled, Abstract 907: Brain microenvironment induced PTEN loss by microRNAs promotes brain metastasis

Journal Articles

EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

Cancer Res (2016) 76 (5): 1284–1296.

https://doi.org/10.1158/0008-5472.CAN-15-2478

Published: 29 February 2016

View articletitled, EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

Includes: Supplementary data

Journal Articles

Abstract 3772: Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer

Cansu Karakas, Ashleigh Francis, Min Yi, Aysegul Sahin, Khandan Keyomarsi, Kelly Hunt

Cancer Res (2015) 75 (15_Supplement): 3772.

https://doi.org/10.1158/1538-7445.AM2015-3772

Published: 01 August 2015

View articletitled, Abstract 3772: Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer

Journal Articles

Abstract 1186: Patient-derived breast cancer xenografts demonstrate molecular evolution in the phosphatidylinositol 3-kinase pathway upon engraftment

Priscilla F. McAuliffe, Argun Akcakanat, Kurt Evans, Agda Karina Eterovic, Hao Zhao, Ken Chen, Takafumi Sangai, Huiqin Chen, Kim-Anh Do, Ashley M. Holder, Chandeshwar Sharma, William Fraser Symmans, Mihai Gagea, Katherine A. Naff, Aysegul Sahin, Asha S. Multani, Gordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

Cancer Res (2014) 74 (19_Supplement): 1186.

https://doi.org/10.1158/1538-7445.AM2014-1186

Published: 01 October 2014

View articletitled, Abstract 1186: Patient-derived breast cancer xenografts demonstrate molecular evolution in the phosphatidylinositol 3-kinase pathway upon engraftment

Journal Articles

Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer

Patricia A. Thompson, Ingrid Ljuslinder, Spyros Tsavachidis, Abenaa Brewster, Aysegul Sahin, Håkan Hedman, Roger Henriksson, Melissa L. Bondy, Beatrice S. Melin

Cancer Res (2014) 74 (11): 2928–2935.

https://doi.org/10.1158/0008-5472.CAN-13-2112

Published: 29 May 2014

View articletitled, Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer

Includes: Supplementary data

Journal Articles

Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer

Thuy T. Vu, Terry Shackleford, Qingxiu Zhang, Do-Youn Oh, Zhou Fuling, Yunbao Pan, Ling Tian, Ilias Drakos, Georgios Rassidakis, Xiao-Feng Le, Aysegul Sahin, Timothy Kute, Francois Claret

Cancer Res (2012) 72 (8_Supplement): 1912.

https://doi.org/10.1158/1538-7445.AM2012-1912

Published: 15 April 2012

View articletitled, Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer

Journal Articles

Abstract LB-193: Ganglioside GD2 identifies cancer stem cells and inhibition of GD2 biosynthesis by targeting GD3 synthase exerts antitumor effects

Venkata Lokesh Battula, Yuexi Shi, Kurt Evans, Rui-Yu Wang, Erika L. Speath, Rodrigo Jacamo, Rudy Guerra, Aysegul Sahin, Frank Marini, Sendurai Mani, Micheal Andreeff

Cancer Res (2012) 72 (8_Supplement): LB-193.

https://doi.org/10.1158/1538-7445.AM2012-LB-193

Published: 15 April 2012

View articletitled, Abstract LB-193: Ganglioside GD2 identifies cancer stem cells and inhibition of GD2 biosynthesis by targeting GD3 synthase exerts antitumor effects

Journal Articles

Abstract LB-379: Combating trastuzumab resistance by targeting Src, a common node downstream of multiple resistance pathways

Siyuan Zhang, Wen-Chien Huang, Ping Li, Hua Guo, Say-Bee Poh, Samuel Brady, Yan Xiong, Ling-Ming Tseng, Shau-Hsuan Li, Zhaoxi Ding, Aysegul Sahin, Francisco Esteva, Gabriel Hortobagyi, Dihua Yu

Cancer Res (2011) 71 (8_Supplement): LB-379.

https://doi.org/10.1158/1538-7445.AM2011-LB-379

Published: 15 April 2011

View articletitled, Abstract LB-379: Combating trastuzumab resistance by targeting Src, a common node downstream of multiple resistance pathways

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4613: Differential TROP2 immunohistochemical expression between pleomorphic and classic invasive lobular carcinoma of the breast

Low–Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

Abstract PO3-15-03: Abemaciclib is effective in palbociclib resistant estrogen receptor positive breast cancers

Abstract P2-21-07: Exploring spatial correlations in Breast invasive Lobular Carcinoma subtypes using a novel CAF multiplex immunofluorescence panel

Abstract 1798: Mechanisms of acquired resistance to palbociclib reveals pathways of response to abemaciclib

Abstract 515: Single-cell transcriptomic analysis of HR+/HER2- breast cancer identifies gene signatures that predict outcomes of luminal A and B subtypes

Abstract P4-07-13: An exploratory case-control study of perineural invasion in breast cancer

Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)

Abstract PS18-37: Loss of Trop2 protein in metaplastic carcinoma of breast by IHC

Abstract P4-06-03: Assessment of intratumoral heterogeneity in early stage estrogen receptor (ER) positive breast cancer

Abstract P1-18-20: Breast cancer with HER2 FISH test result in group 2: Should HER2 test be repeated?

Abstract 1105: Tumor cells of the early metastatic process show up regulation of cytokine genes involved in migration of inflammatory cells

Abstract 907: Brain microenvironment induced PTEN loss by microRNAs promotes brain metastasis

EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape

Abstract 3772: Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer

Abstract 1186: Patient-derived breast cancer xenografts demonstrate molecular evolution in the phosphatidylinositol 3-kinase pathway upon engraftment

Loss of LRIG1 Locus Increases Risk of Early and Late Relapse of Stage I/II Breast Cancer

Abstract 1912: Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer

Abstract LB-193: Ganglioside GD2 identifies cancer stem cells and inhibition of GD2 biosynthesis by targeting GD3 synthase exerts antitumor effects

Abstract LB-379: Combating trastuzumab resistance by targeting Src, a common node downstream of multiple resistance pathways

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only